Waterstones, 19-21 Tottenham Court Rd, London W1T 1BJ
27 November 2017
Join Tom Wainwright, author of 'Narconomics', in a panel discussion on Latin America’s drug war, its human and financial costs, and how this impacts other countries.
The Association for Safer Drug Policies has invited some of the world’s leading voices in drug policy reform to share their harm prevention strategies.
Now in its fifth year and the third time hepatitis testing has been included, European HIV-Hepatitis Testing Week will take place from 17-24 November 2017.
The Thirty-ninth meeting of the Expert Committee on Drug Dependence (ECDD) will be held in Geneva, Switzerland, 6 – 10 November 2017.
At the meeting, the ECDD will review a number of psychoactive substances with potential for dependence, abuse and harm to health and make recommendations to the UN Secretary-General, on the need for and level of international control of these substances. The following substances will be reviewed:
1. Ocfentanil 2. Furanyl fentanyl (Fu-F) 3. Acryloylfentanyl (Acrylfentanyl) 4. Carfentanil 5. 4-fluoroisobutyrfentanyl (4-FIBF, pFIBF) 6. Tetrahydrofuranylfentanyl (THF-F) 7. 4-fluoroamphetamine (4-FA) 8. AB-PINACA 9. AB-CHMINACA 10. 5F-PB-22 11. UR-144 12. 5F-ADB 13. Etizolam 14. Pregabalin 15. Tramadol 16. Cannabidiol (CBD).
For more information, please do not hesitate to contact the Secretariat at: ecddsecretariat@who.int
A free pop-up exhibition and cultural hub featuring live programming and art from around the world, highlighting how drug policies impact and shape our communities.
The 2017 theme is "Implementing the Global Health Sector Strategy on Viral Hepatitis (GHSS): Towards the elimination of hepatitis as a public health threat".
This Intersessional Briefing will provide information to delegates and serves as a platform for discussion on how the human rights system can contribute to the ongoing process, supplementing work by other agencies in the UN system and delivering on its mandate.